-
Signature
-
/s/ Kimberly Cornwell as attorney-in-fact for Ilan Ganot
-
Issuer symbol
-
SLDB
-
Transactions as of
-
27 Jan 2026
-
Net transactions value
-
-$1,259
-
Form type
-
4
-
Filing time
-
30 Jan 2026, 16:05:07 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Ganot Ilan |
Director |
C/O SOLID BIOSCIENCES INC., 500 RUTHERFORD AVENUE, THIRD FLOOR, CHARLESTOWN |
/s/ Kimberly Cornwell as attorney-in-fact for Ilan Ganot |
29 Jan 2026 |
0001727460 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
SLDB |
Common Stock |
Options Exercise |
|
+389 |
+2.3% |
|
17,667 |
27 Jan 2026 |
Wife |
F1 |
| transaction |
SLDB |
Common Stock |
Sale |
$1,259 |
-191 |
-1.1% |
$6.59 |
17,476 |
28 Jan 2026 |
Wife |
F2 |
| transaction |
SLDB |
Common Stock |
Options Exercise |
|
+3,884 |
+4.1% |
|
99,297 |
27 Jan 2026 |
Direct |
F1, F3 |
| holding |
SLDB |
Common Stock |
|
|
|
|
|
19,394 |
27 Jan 2026 |
See Footnote |
F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
SLDB |
Restricted Stock Units |
Options Exercise |
$0 |
-389 |
-100% |
$0.000000 |
0 |
27 Jan 2026 |
Common Stock |
389 |
|
Wife |
F1, F5 |
| transaction |
SLDB |
Restricted Stock Units |
Options Exercise |
$0 |
-3,884 |
-100% |
$0.000000 |
0 |
27 Jan 2026 |
Common Stock |
3,884 |
|
Direct |
F1, F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: